SCHEMBL4555142

SCHEMBL4555142

CC(C)Oc1ccc(C(=O)NC(CNC(=O)[C@H](C)N)Cc2ccc(-c3cn4cccc(Br)c4n3)cc2)cc1Cl

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CENPE Q02224 3/20 0.68
KIFC1 Q9BW19 1/20 0.41
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A2 O94788 1/20 0.36
ALDH1A3 P47895 1/20 0.36
PPARG P37231 1/20 0.34
S1PR1 P21453 5/20 0.34
MAP4K4 O95819 1/20 0.34
MINK1 Q8N4C8 1/20 0.34
S1PR3 Q99500 1/20 0.34
S1PR5 Q9H228 1/20 0.34
WDR5 P61964 1/20 0.34
NPC1 O15118 1/20 0.33
RECQL P46063 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13644396 1.00 CENPE (0.68) CENPEKIFC1ALDH1A1KDM4EMAPT
SCHEMBL13162047 1.00 CENPE (0.68) CENPEKIFC1ALDH1A1KDM4EMAPT
SCHEMBL2104812 1.00 CENPE (0.68) CENPEKIFC1ALDH1A1KDM4EMAPT
SCHEMBL2103746 1.00 CENPE (0.68) CENPEKIFC1ALDH1A1KDM4EMAPT
SCHEMBL13161858 0.94 CENPE (0.66) CENPEKIFC1ALDH1A1KDM4EMAPT
SCHEMBL13161822 0.94 CENPE (0.66) CENPEKIFC1ALDH1A1KDM4EMAPT
SCHEMBL3462504 0.94 CENPE (0.66) CENPEKIFC1ALDH1A1KDM4EMAPT
SCHEMBL13161647 0.94 CENPE (0.71) CENPEKIFC1ALDH1A1KDM4EMAPT
SCHEMBL2103889 0.94 CENPE (0.71) CENPEKIFC1ALDH1A1KDM4EMAPT
SCHEMBL3460971 0.93 CENPE (0.68) CENPEKIFC1ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618981-B2 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide CYTOKINETICS, INC. (US) 2009-11-17 US disclosed